XINTHERA

xinthera-logo

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.

#SimilarOrganizations #People #Financial #Website #More

XINTHERA

Social Links:

Industry:
Biotechnology Health Care Life Science

Founded:
2021-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.xinthera.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
50 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online


Similar Organizations

catena-biosciences-logo

Catena Biosciences

Biotech company focused on protein conjugation.

enliven-therapeutics-logo

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

erasca-logo

Erasca

Erasca is a developer of oncology drugs intended to provide precision oncology options.

indygeneus-ai-logo

IndyGeneUS AI

IndyGeneUS AI is a genomics company building a digital blockchain-encrypted bio-bank.

seismic-therapeutic-logo

Seismic Therapeutic

Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

carl-l-gordon_image

Carl L. Gordon Board Member @ XinThera
Board_member
2021-08-01

michael-rome_image

Michael Rome Board Member @ XinThera
Board_member

jim-tananbaum_image

Jim Tananbaum Board Member @ XinThera
Board_member
2021-08-01

Current Employees Featured

gene-hung_image

Gene Hung
Gene Hung Co-founder and Senior Vice President @ XinThera
Co-founder and Senior Vice President

stephen-kaldor_image

Stephen Kaldor
Stephen Kaldor Co-Founder and Chairman @ XinThera
Co-Founder and Chairman

qing-dong_image

Qing Dong
Qing Dong President & CSO @ XinThera
President & CSO

Founder


gene-hung_image

Gene Hung

qing-dong_image

Qing Dong

stephen-kaldor_image

Stephen Kaldor

Investors List

foresite-capital_image

Foresite Capital

Foresite Capital investment in Series B - XinThera

ttm-capital_image

TTM Capital

TTM Capital investment in Series B - XinThera

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - XinThera

ttm-capital_image

TTM Capital

TTM Capital investment in Series A - XinThera

Official Site Inspections

http://www.xinthera.com Semrush global rank: 5.49 M Semrush visits lastest month: 1.56 K

  • Host name: 165.160.13.20
  • IP address: 165.160.13.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "XinThera"

XinThera - Crunchbase Company Profile & Funding

XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.See details»

XinThera - Org Chart, Teams, Culture & Jobs - The Org

View XinThera's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

XinThera Company Profile | Management and Employees List

XinThera Profile and History. Based in San Diego, California, XinThera is a biotechnology company focused on developing a small molecule oncology and immunology pipeline.See details»

XinThera, Inc. Company Profile | San Diego, CA | Competitors ...

Find company research, competitor information, contact details & financial data for XinThera, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»

XinThera - Contacts, Employees, Board Members, Advisors & Alumni

Edit Board Member and Advisor Profiles Section. Number of Board Member and Advisor Profiles 3. XinThera has 3 board members and advisors, including Carl L. Gordon.See details»

XinThera Company Profile 2024: Valuation, Investors ... - PitchBook

XinThera General Information Description. Developer of precision medicines intended to treat cancer and immunologic diseases. The company applies advanced computational chemistry โ€ฆSee details»

XinThera - VentureRadar

Similar Companies: Kinnate Biopharma USA Publicly Traded By leveraging our deep expertise in structure-based drug discovery, translational research and patient-driven precision medicine, โ€ฆSee details»

XinThera - Overview, News & Similar companies | ZoomInfo.com

May 9, 2023 View XinThera (www.xinthera.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Gilead Strengthens Early Pipeline in Oncology and Inflammation โ€ฆ

May 9, 2023 Gilead Sciences, Inc. (Nasdaq: GILD) today announced the acquisition of all outstanding shares of XinThera, a privately held biotech company in San DiSee details»

XinThera - Company Profile - Tracxn

Oct 25, 2024 XinThera ranks 276th among 2365 active competitors. 850 of its competitors are funded while 543 have exited. Overall, XinThera and its competitors have raised over $79.2B โ€ฆSee details»

Gilead boosts oncology pipeline with XinThera acquisition

May 9, 2023 Gilead Sciences, Inc. has announced the acquisition of all outstanding shares of XinThera, a privately held biotech company in San Diego. Gilead Sciences said the acquisition โ€ฆSee details»

Gilead Science acquires Xin Thera - Medthority

May 10, 2023 Gilead Sciences, Inc. announced the acquisition of all outstanding shares of XinThera, a privately held biotech company in San Diego. The acquisition complements โ€ฆSee details»

XinThera buy builds Gileadโ€™s cancer, inflammation pipeline

4 days ago Gilead Sciences has bulked up its early-stage R&D portfolio with an agreement to buy XinThera, adding drugs targeting PARP for oncology and MK2 for inflammatory diseases.See details»

Gilead Sciences buys XinThera to boost oncology and inflammation

May 10, 2023 The acquisition expands Gilead Sciencesโ€™ oncology and inflammation pipeline. Credit: National Cancer Institute on Unsplash.See details»

Home | Xintera BV

Xintera. Making evidence work. Constructing the estimand. A successful development starts with the construction of a suitable estimand . An estimand has five attributes: the treatment itself, โ€ฆSee details»

Gilead acquires XinThera to bolster oncology and inflammation โ€ฆ

May 9, 2023 Gilead Sciences has acquired XinThera in an effort to bolster its oncology and inflammation pipeline, the company announced Tuesday. The acquisition will give Gilead โ€ฆSee details»

Xinterra - Crunchbase Company Profile & Funding

Jun 7, 2024 Xinterra is a materials-centric company that helps develop new materials that are essential for sustainable products and applications. It unlocks innovation to radically โ€ฆSee details»

xinterra โ€“ A new world of materials

Xinterra team is a diverse network of materials scientists, engineers and industry professionals with a global mindset and a collaborative culture.See details»

Outcomes | Xintera BV

Core value dossier creation โ€“ including local adaptations; Communication strategy & publication planning; Design and execute value-added Phase 4 study protocolsSee details»

Xintera Company Profile | Gent, Oost-Vlaanderen, Belgium

Find company research, competitor information, contact details & financial data for Xintera of Gent, Oost-Vlaanderen. Get the latest business insights from Dun & Bradstreet. Xintera. D&B โ€ฆSee details»

linkstock.net © 2022. All rights reserved